Multiple Myeloma Insights

Specialty pharmacies: a guide for multiple myeloma patients & carers

February 06, 2025

Exclusive Report

Specialty pharmacies: a guide for multiple myeloma patients & carers

Exciting breakthroughs in rare disease treatments mean more patients are gaining access to cutting-edge therapies - and specialty pharmacies are playing a crucial role in delivering these medications with expert support. But what exactly do they do, and when do they come into play?

AllMyHealth’s latest guide breaks it all down - exploring how specialty pharmacies work, their expanding role in patient care, and how individuals can engage with them. Plus, we spotlight some specialty pharmacies that cater to multiple myeloma.

Available in both text and audio formats - dive in today and share with your community!

View the Full Report

The report is available for free online on the AllMyHealth website.

www.allmyhealth.io/reports

Latest Research

In a study by Gregorova et al. (2025), researchers investigated the role of microRNAs in the progression of multiple myeloma, a type of blood cancer. They analyzed the expression of microRNAs in bone marrow plasma from patients with multiple myeloma, extramedullary disease, and plasma cell leukemia. The study identified 42 microRNAs that were significantly dysregulated among the patient subgroups. Notably, four microRNAs (miR-140-3p, miR-584-5p, miR-191-5p, and miR-143-3p) were found to be elevated in multiple myeloma patients when compared to those with more aggressive forms of the disease.

Further analysis showed significant correlations between the expression of these microRNAs and the patients' clinical characteristics, as well as flow cytometry parameters, which are measures of cell characteristics. These findings suggest that changes in microRNA levels could be contributing to the progression of multiple myeloma, and they may serve as potential markers for disease status or targets for new treatments. Gregorova et al. confirmed these results using RT-qPCR, a technique for measuring the amount of specific microRNAs, thereby validating the initial findings from their RNA sequencing approach.

Community News

Myeloma UKFeb 04, 2025

This World Cancer Day, we're recognising the unique stories and experiences of people living with myeloma and the importance of people-centred cancer care.

More than 24,000 people are living with myeloma in the UK. Everyone's myeloma experience is individual and deeply personal, but we are united in our message.

Together, we are the cure.

Multiple MyelomaFeb 02, 2025

I'm very young qnd just got diagnosed yesturday with MM, I'm 34 years old ... I have no idea what the next steps are I've been hospitalized for 2 weeks and today I talk to the doctors about treatment and the next steps but I'd like to hear other people's stories of the beginning of their diagnosis. Also if anyone lives in Okanagan BC Canada that my want to become friends.